Dr. Mitchell Shiffman, MD
Claim this profileBon Secours Liver Institute of Virginia - Newport News
Studies Non-alcoholic Fatty Liver Disease
Studies Cholangitis
12 reported clinical trials
16 drugs studied
Area of expertise
1Non-alcoholic Fatty Liver Disease
Stage I
Stage II
2Cholangitis
Affiliated Hospitals
Clinical Trials Mitchell Shiffman, MD is currently running
HM15211
for Non-alcoholic Steatohepatitis (NASH)
This trial is testing a medication called HM15211 to see if it can help people with a liver disease called NASH. The study will check if the medication is safe and effective over a period of time.
Recruiting0 awards Phase 23 criteria
Lanifibranor
for Nonalcoholic Steatohepatitis (NASH)
This Phase 3 study is conducted to evaluate lanifibranor in adults with NASH and liver fibrosis histological stage F2 or F3
Recruiting1 award Phase 31 criteria
More about Mitchell Shiffman, MD
Clinical Trial Related4 years of experience running clinical trials · Led 12 trials as a Principal Investigator · 5 Active Clinical TrialsTreatments Mitchell Shiffman, MD has experience with
- Placebo
- Belapectin
- Volixibat
- HTD1801 (BUDCA)
- Bezafibrate
- Obeticholic Acid
Breakdown of trials Mitchell Shiffman, MD has run
Non-alcoholic Fatty Liver Disease
Cholangitis
Liver Cirrhosis
Fatty Liver Disease
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Mitchell Shiffman, MD specialize in?
Mitchell Shiffman, MD focuses on Non-alcoholic Fatty Liver Disease and Cholangitis. In particular, much of their work with Non-alcoholic Fatty Liver Disease has involved Stage I patients, or patients who are Stage II.
Is Mitchell Shiffman, MD currently recruiting for clinical trials?
Yes, Mitchell Shiffman, MD is currently recruiting for 4 clinical trials in Newport News Virginia. If you're interested in participating, you should apply.
Are there any treatments that Mitchell Shiffman, MD has studied deeply?
Yes, Mitchell Shiffman, MD has studied treatments such as Placebo, Belapectin, Volixibat.
What is the best way to schedule an appointment with Mitchell Shiffman, MD?
Apply for one of the trials that Mitchell Shiffman, MD is conducting.
What is the office address of Mitchell Shiffman, MD?
The office of Mitchell Shiffman, MD is located at: Bon Secours Liver Institute of Virginia - Newport News, Newport News, Virginia 23602 United States. This is the address for their practice at the Bon Secours Liver Institute of Virginia - Newport News.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.